Clinical Trial

Washed Microbiota Transplantation for Tourette's Syndrome

Study acronym: WMT
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study aimed to evaluate the efficacy of washed microbiota transplantation in the treatment of Tourette's syndrome (TS).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2018-12-03; most recent amendment 2024-08-15.
Trial Details
NCT Number NCT03764748
Lead Sponsor The Second Hospital of Nanjing Medical University
Collaborators: Nanjing Medical University
Conditions Tourette Syndrome
Enrollment 30 participants
Start Date 2024-04-17
Primary Completion 2027-10-31 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-19